Originalkatalog | Verfügbarkeit prüfen

DOP069 Natural history of dysplasia and colorectal cancer in IBD patients in Belgium tertiary care centers

Cremer, A., Liefferinckx, C., De Vos, M., Rahier, J.-F., Baert, F., Moreels, T., Macken, E., Louis, E., Devière, J., Van Gossum, A., Vermeire, S., Franchimont, D.
Veröffentlicht in: Journal of Crohn's and Colitis ; volume 11, issue suppl_1, page S67-S67 ; ISSN 1873-9946 1876-4479;
2017

Originalkatalog | Verfügbarkeit prüfen

Belgian IBD research group (BIRD) position statement 2017 on the use of biosimilars in inflammatory bowel diseases (IBD).

Franchimont, D., Ferrante, M., Louis, Edouard, De Vos, M., Dewit, O., Van Hootegem, P., Moreels, T., Liefferinckx, C., Bossuyt, P., Baert, F., Rahier, Jean-François, Vermeire, S.
2018

Originalkatalog | Verfügbarkeit prüfen

DOP003 Ustekinumab induces clinical and biological remission in biologic refractory Crohn’s disease patients: A real-world belgian cohort study

Liefferinckx, C, Verstockt, B, Gils, A, Noman, M, Van Kemseke, C, Macken, E, De Vos, M, Van Moerkercke, W, Rahier, J -F, Bossuyt, P, Dutré, J, Humblet, E, Staessen, D, Peeters, H, Van Hootegem, P, Louis, E, Franchimont, D, Baert, F, Vermeire, S
Veröffentlicht in: Journal of Crohn's and Colitis ; volume 12, issue supplement_1, page S031-S032 ; ISSN 1873-9946 1876-4479;
2018